Cargando…

Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation

ABSTRACT: Alzheimer’s disease (AD) is characterized by intracerebral deposition of abnormal proteinaceous assemblies made of amyloid-β (Aß) peptides or tau proteins. These peptides and proteins induce synaptic dysfunctions that are strongly correlated with cognitive decline. Intracerebral infusion o...

Descripción completa

Detalles Bibliográficos
Autores principales: Célestine, Marina, Jacquier-Sarlin, Muriel, Borel, Eve, Petit, Fanny, Perot, Jean-Baptiste, Hérard, Anne-Sophie, Bousset, Luc, Buisson, Alain, Dhenain, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122826/
https://www.ncbi.nlm.nih.gov/pubmed/37087498
http://dx.doi.org/10.1186/s40478-023-01559-0
_version_ 1785029566681579520
author Célestine, Marina
Jacquier-Sarlin, Muriel
Borel, Eve
Petit, Fanny
Perot, Jean-Baptiste
Hérard, Anne-Sophie
Bousset, Luc
Buisson, Alain
Dhenain, Marc
author_facet Célestine, Marina
Jacquier-Sarlin, Muriel
Borel, Eve
Petit, Fanny
Perot, Jean-Baptiste
Hérard, Anne-Sophie
Bousset, Luc
Buisson, Alain
Dhenain, Marc
author_sort Célestine, Marina
collection PubMed
description ABSTRACT: Alzheimer’s disease (AD) is characterized by intracerebral deposition of abnormal proteinaceous assemblies made of amyloid-β (Aß) peptides or tau proteins. These peptides and proteins induce synaptic dysfunctions that are strongly correlated with cognitive decline. Intracerebral infusion of well-defined Aβ seeds from non-mutated Aβ(1-40) or Aβ(1-42) peptides can increase Aβ depositions several months after the infusion. Familial forms of AD are associated with mutations in the amyloid precursor protein (APP) that induce the production of Aβ peptides with different structures. The Aβ Osaka (Aβ(osa) mutation (E693Δ)) is located within the Aβ sequence and thus the Aβ(osa) peptides have different structures and properties as compared to non-mutated Aβ(1-42) peptides (Aβ(wt)). Here, we wondered if a single exposure to this mutated Aβ can worsen AD pathology as well as downstream events including cognition, cerebral connectivity and synaptic health several months after the inoculation. To answer this question we inoculated Aβ(1-42)-bearing Osaka mutation (Aβ(osa)) in the dentate gyrus of APP(swe)/PS1(dE9) mice at the age of two months. Their cognition and cerebral connectivity were analyzed at 4 months post-inoculation by behavioral evaluation and functional MRI. Aβ pathology as well as synaptic density were evaluated by histology. The impact of Aβ(osa) peptides on synaptic health was also measured on primary cortical neurons. Remarkably, the intracerebral administration of Aβ(osa) induced cognitive and synaptic impairments as well as a reduction of functional connectivity between different brain regions, 4 months post-inoculation. It increased Aβ plaque depositions and increased Aβ oligomers. This is the first study showing that a single, sporadic event as Aβ(osa) inoculation can worsen the fate of the pathology and clinical outcome several months after the event. It suggests that a single inoculation of Aβ regulates a large cascade of events for a long time. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-10122826
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101228262023-04-24 Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation Célestine, Marina Jacquier-Sarlin, Muriel Borel, Eve Petit, Fanny Perot, Jean-Baptiste Hérard, Anne-Sophie Bousset, Luc Buisson, Alain Dhenain, Marc Acta Neuropathol Commun Research ABSTRACT: Alzheimer’s disease (AD) is characterized by intracerebral deposition of abnormal proteinaceous assemblies made of amyloid-β (Aß) peptides or tau proteins. These peptides and proteins induce synaptic dysfunctions that are strongly correlated with cognitive decline. Intracerebral infusion of well-defined Aβ seeds from non-mutated Aβ(1-40) or Aβ(1-42) peptides can increase Aβ depositions several months after the infusion. Familial forms of AD are associated with mutations in the amyloid precursor protein (APP) that induce the production of Aβ peptides with different structures. The Aβ Osaka (Aβ(osa) mutation (E693Δ)) is located within the Aβ sequence and thus the Aβ(osa) peptides have different structures and properties as compared to non-mutated Aβ(1-42) peptides (Aβ(wt)). Here, we wondered if a single exposure to this mutated Aβ can worsen AD pathology as well as downstream events including cognition, cerebral connectivity and synaptic health several months after the inoculation. To answer this question we inoculated Aβ(1-42)-bearing Osaka mutation (Aβ(osa)) in the dentate gyrus of APP(swe)/PS1(dE9) mice at the age of two months. Their cognition and cerebral connectivity were analyzed at 4 months post-inoculation by behavioral evaluation and functional MRI. Aβ pathology as well as synaptic density were evaluated by histology. The impact of Aβ(osa) peptides on synaptic health was also measured on primary cortical neurons. Remarkably, the intracerebral administration of Aβ(osa) induced cognitive and synaptic impairments as well as a reduction of functional connectivity between different brain regions, 4 months post-inoculation. It increased Aβ plaque depositions and increased Aβ oligomers. This is the first study showing that a single, sporadic event as Aβ(osa) inoculation can worsen the fate of the pathology and clinical outcome several months after the event. It suggests that a single inoculation of Aβ regulates a large cascade of events for a long time. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2023-04-22 /pmc/articles/PMC10122826/ /pubmed/37087498 http://dx.doi.org/10.1186/s40478-023-01559-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Célestine, Marina
Jacquier-Sarlin, Muriel
Borel, Eve
Petit, Fanny
Perot, Jean-Baptiste
Hérard, Anne-Sophie
Bousset, Luc
Buisson, Alain
Dhenain, Marc
Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation
title Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation
title_full Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation
title_fullStr Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation
title_full_unstemmed Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation
title_short Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation
title_sort long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with osaka mutation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122826/
https://www.ncbi.nlm.nih.gov/pubmed/37087498
http://dx.doi.org/10.1186/s40478-023-01559-0
work_keys_str_mv AT celestinemarina longtermworseningofamyloidpathologycerebralfunctionandcognitionafterasingleinoculationofbetaamyloidseedswithosakamutation
AT jacquiersarlinmuriel longtermworseningofamyloidpathologycerebralfunctionandcognitionafterasingleinoculationofbetaamyloidseedswithosakamutation
AT boreleve longtermworseningofamyloidpathologycerebralfunctionandcognitionafterasingleinoculationofbetaamyloidseedswithosakamutation
AT petitfanny longtermworseningofamyloidpathologycerebralfunctionandcognitionafterasingleinoculationofbetaamyloidseedswithosakamutation
AT perotjeanbaptiste longtermworseningofamyloidpathologycerebralfunctionandcognitionafterasingleinoculationofbetaamyloidseedswithosakamutation
AT herardannesophie longtermworseningofamyloidpathologycerebralfunctionandcognitionafterasingleinoculationofbetaamyloidseedswithosakamutation
AT boussetluc longtermworseningofamyloidpathologycerebralfunctionandcognitionafterasingleinoculationofbetaamyloidseedswithosakamutation
AT buissonalain longtermworseningofamyloidpathologycerebralfunctionandcognitionafterasingleinoculationofbetaamyloidseedswithosakamutation
AT dhenainmarc longtermworseningofamyloidpathologycerebralfunctionandcognitionafterasingleinoculationofbetaamyloidseedswithosakamutation